Health Condition 1: J989- Respiratory disorder, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Amrita Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: All paediatric patients admitted in PICU initiated on High flow nasal cannula and whose parents consent for participation will be included
Exclusion criteria
Exclusion criteria: Patients with hemodynamic instability or GCS less than 12 or tracheostomy or nasal bleed or CSF rhinorrhoea or facial deformity or patients cycled between HFNC and NIV or Patients in whom HFNC abruptly stopped for major surgical intervention requiring invasive ventilatory support
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prediction of HFNC therapy outcome, defined as success ( successful weaning off HFNC) or failure of HFNC support (based on need for escalation to non invasive or invasive ventilation).Timepoint: At predefined assessment intervals after initiation of HFNC, namely 2, 4, 6, 12, 18, 24, and 48 hours, and daily thereafter and at the point of clinical decision making such as escalation to non invasive or invasive ventilation or successful weaning off from HFNC | — |
Secondary
| Measure | Time frame |
|---|---|
| Description of clinical spectrum of HFNC use in PICU including indications patient characteristics duration of HFNC & overall clinical course during PICU stayTimepoint: Across PICU stay including at initiation of HFNC & assessments at 2, 4, 6, 12, 18, 24, & 48 hours & daily thereafter till end of HFNC therapy along with final outcomes such as duration of HFNC & total length of PICU stay | — |
Countries
India
Contacts
Public ContactDr Veena Raghunathan
Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham
Outcome results
None listed